Showing results (1721-1730 of 1,799) with videos related to

Sort By:
Pageof 180
Mabs|February 18, 2025
Achieving Acceleration to First-in-Human: MSD's Learnings on Platform Method Validation StrategyXiaoqing Hua, Jorge Quiroz, Joop Waterval, et al.
Mabs|January 30, 2025
Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC studyJennifer Moore, Alicia Aylott, Wen-Hung Chen, et al.
Mabs|March 17, 2025
A novel in vitro serum stability assay for antibody therapeutics incorporating internal standardsYihan Li, Rosendo Villafuerte-Vega, Vikram M Shenoy, et al.
Mabs|January 8, 2025
Prediction of protein biophysical traits from limited data: a case study on nanobody thermostability through NanoMeltAubin Ramon, Mingyang Ni, Olga Predeina, et al.
Mabs|January 6, 2025
A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor-specificityAlyssa Synan, Nila C Wu, Roberto Velazquez, et al.
Mabs|March 5, 2025
Folate receptor alpha for cancer therapy: an antibody and antibody-drug conjugate target coming of ageYi Liu, Xinyi Chen, Theodore Evan, et al.
Mabs|February 28, 2025
Prediction of long-term stability of high-concentration formulations to support rapid development of antibodies against SARS-CoV-2Lin Luo, Michael Meleties, Julie Beaudet, et al.
Mabs|August 27, 2024
Developability considerations for bispecific and multispecific antibodiesAlaa Amash, Gesa Volkers, Patrick Farber, et al.
Mabs|August 28, 2024
Expanding the structural resolution of glycosylation microheterogeneity in therapeutic proteins by salt-free hydrophilic interaction liquid chromatography tandem mass spectrometryYutian Gan, Steffen Lippold, John Stobaugh, et al.
Mabs|November 25, 2024
Agonistic anti-NKG2D antibody structure reveals unique stoichiometry and epitope compared to natural ligandsDaniel Fallon, Ching-Shin Huang, Jingya Ma, et al.
Pageof 180